Cargando…
Exogenous alpha 1-antitrypsin down-regulates SERPINA1 expression
The main goal of the therapy with purified human plasma alpha1-antitrypsin (A1AT) is to increase A1AT levels and to prevent lungs from elastolytic activity in patients with PiZZ (Glu(342)Lys) A1AT deficiency-related emphysema. Potential hepatic gains of this therapy are unknown. Herein, we investiga...
Autores principales: | Karadagi, Ahmad, Johansson, Helene, Zemack, Helen, Salipalli, Sandeep, Mörk, Lisa-Mari, Kannisto, Kristina, Jorns, Carl, Gramignoli, Roberto, Strom, Stephen, Stokkeland, Knut, Ericzon, Bo-Göran, Jonigk, Danny, Janciauskiene, Sabina, Nowak, Greg, Ellis, Ewa C. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423693/ https://www.ncbi.nlm.nih.gov/pubmed/28486562 http://dx.doi.org/10.1371/journal.pone.0177279 |
Ejemplares similares
-
Clinical Significance of SERPINA1 Gene and Its Encoded Alpha1-Antitrypsin Protein in NSCLC
por: Ercetin, Evrim, et al.
Publicado: (2019) -
Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency
por: Matamala, Nerea, et al.
Publicado: (2015) -
Systemic modified messenger RNA for replacement therapy in alpha 1-antitrypsin deficiency
por: Karadagi, Ahmad, et al.
Publicado: (2020) -
De Novo Donor‐Specific HLA Antibody Formation in Two Patients With Crigler‐Najjar Syndrome Type I Following Human Hepatocyte Transplantation With Partial Hepatectomy Preconditioning
por: Jorns, C., et al.
Publicado: (2015) -
Why do some adults with PiMZ α(1)-antitrypsin develop bronchiectasis?
por: Aggarwal, Nupur, et al.
Publicado: (2016)